Stay updated on MEDI4736 in Myelodysplastic Syndrome Clinical Trial

Sign up to get notified when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites by state (Arizona, California, Connecticut, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New York, South Carolina, Texas, Wisconsin). The revision note shows the page updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-22T22:37:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision changed from v3.3.1 to v3.3.2 on the page, a minor system update that does not affect study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:31:41.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the study page; this appears to be a metadata/version update and does not alter study details, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T11:24:05.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The funding-related notice at the top of the page has been removed. This was a generic site-wide alert and does not change the study details or eligibility information presented on the page.
    Difference
    0.3%
    Check dated 2025-11-17T06:14:25.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The Study Details page appears unchanged between the two screenshots; no major sections or data were added or removed. The information about MEDI4736, Tremelimumab, azacitidine, eligibility, and locations remains as shown.
    Difference
    0.4%
    Check dated 2025-11-03T00:50:55.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T08:08:55.000Z thumbnail image

Stay in the know with updates to MEDI4736 in Myelodysplastic Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI4736 in Myelodysplastic Syndrome Clinical Trial page.